CANCER RESEARCH UK - United Kingdom 

Ranking results:

Past rankings:

2015
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:800-900
Total Number of Projects:600-700
Networking Rank (Reputation):> 1000
Partner Constancy:600-700
Project Leadership Index:700-800
2014
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):> 1000
Partner Constancy:100-200
Project Leadership Index:100-200
Diversity Index:300-400
2013
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:100-200
Total Number of Projects:65
Total Project Funding:700-800
Partner Constancy:58
Project Leadership Index:69
Diversity Index:64
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:300-400
Total Number of Projects:66
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:23
2011
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:90
Total Number of Projects:100-200
Total Project Funding:500-600
Networking Rank (Reputation):700-800
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:800-900
Total Project Funding per Partner:68
Total Number of Projects:100-200
Total Project Funding:400-500
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:300-400
Total Number of Projects:200-300
Total Project Funding:500-600
Networking Rank (Reputation):800-900
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Total Project Funding:900-1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:900-1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 56
As coordinator: 0
As participant: 25
Sole participant: 31
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2017 0 2.629.316 0 1
2015 550.364 504.690 550.364 3 2
2014 905.779 1.999.941 2.051.217 4 1
2013 1.339.315 8.011.126 6.628.707 6 3
2012 382.475 7.709.473 1.382.475 2 3
2011 927.865 22.557.394 3.045.593 5 8
2010 1.912.436 34.214.183 5.952.904 11 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
THE FRANCIS CRICK INSTITUTE LIMITED10
GENOME RESEARCH4
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS3
UNIVERSITY COLLEGE LONDON3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
BAYER PHARMA2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
INSTITUT NATIONAL DU CANCER2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
STICHTING KATHOLIEKE UNIVERSITEIT2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE2
THE UNIVERSITY OF EDINBURGH2
WEIZMANN INSTITUTE OF SCIENCE2
ACADEMISCH ZIEKENHUIS GRONINGEN1
ALLEANZA CONTRO IL CANCRO1
ARM LIMITED1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE1
AXCENTUA PHARMACEUTICALS AB1
BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
CONCENTRIS RESEARCH MANAGEMENT1
DANAFARBER CANCER INSTITUTE INC NON PROFIT CORP DFCI1
DANMARKS TEKNISKE UNIVERSITET1
DEUTSCHES ZENTRUM FUER LUFT UND RAUMFAHRT EV1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH1
FONDATION ARC POUR LA RECHERCHE SUR LE CANCER1
FONDS ZUR FOERDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
FUNDACAO PARA A CIENCIA E A TECNOLOGIA1
FUNDACIO CENTRE DE REGULACIO GENOMICA1
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA1
GENIKI GRAMMATIA EREVNAS KAI TECHNOLOGIAS YPOURGIO PAIDIAS DIA VIOU MATHISIS & THRISKEVMATON1
HORIZON DISCOVERY LIMITED1
INSTITUT CURIE1
INSTITUT FUER MOLEKULARE BIOTECHNOLOGIE1
INSTITUT FUR MOLEKULARE BIOLOGIE GGMBH1
INSTITUT GUSTAVE ROUSSY1
INSTITUT JULES BORDET1
INSTITUTE OF CANCER RESEARCH ROYAL CANCER HOSPITAL1
INSTITUTO DE SALUD CARLOS III1
INSTITUTUL ONCOLOGIC PROF DR ALEXANDRU TRESTIOREANU BUCURESTI1
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW1
ISTITUTO SUPERIORE DI SANITA1
KAROLINSKA INSTITUTE1
KATHOLIEKE UNIVERSITEIT LEUVEN1
KENTROU ELEGHOU & PROLIPSIS NOSIMATON1
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN1
KREFTFORENINGEN1
LAB 21 LIMITED1
LABORATOIRE BIODIM1
LATVIJAS ZINATNU AKADEMIJA1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUNDS UNIVERSITET1
MARTIN LUTHER UNIVERSITAET HALLE WITTENBERG1
MASARYKUV ONKOLOGICKY USTAV1
MILTENYI BIOTEC1
MINISTERO DEL LAVORO DELLA SALUTE E DELLE POLITICHE SOCIALI1
MINISTERO DELL'ISTRUZIONE DELL'UNIVERSITA' E DELLA RICERCA1
MINISTRSTVO ZA IZOBRAZEVANJE ZNANOST IN SPORT1
MINISTRSTVO ZA VISOKO SOLSTVO ZNANOST IN TEHNOLOGIJO1
MINISTRY OF HEALTH1
NARODOWE CENTRUM BADAN I ROZWOJU1
NATIMAB THERAPEUTICS1
NATURWISSENSCHAFTLICHES UND MEDIZINISCHES INSTITUT AN DER UNIVERSITAET TUEBINGEN1
NETHERLANDS TRANSLATIONAL RESEARCH CENTER BV1
NOKIA OYJ1
NORGES FORSKNINGSRAD1
NOVARTIS FORSCHUNGSSTIFTUNG ZWEIGNIEDERLASSUNG FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH1
ORSZAGOS ONKOLOGIAI INTEZET1
OSLO UNIVERSITETSSYKEHUS HF1
PHILIPPS UNIVERSITAET MARBURG1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
REGIONE LIGURIA1
SEMMELWEIS EGYETEM1
SLOANKETTERING INSTITUTE FOR CANCER RESEARCH CORPORATION1
SLOVENSKA AKADEMIA VIED1
STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK1
STICHTING KONINGIN WILHELMINA FONDS VOOR DE NEDERLANDSE KANKERBESTRIJDING1
TECHNISCHE UNIVERSITAET MUENCHEN1
THE BABRAHAM INSTITUTE1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE NETHERLANDS ORGANISATION FOR HEALTH RESEARCH AND DEVELOPMENT1
THE ROYAL MARSDEN NATIONAL HEALTH SERVICE TRUST1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF MANCHESTER1
TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU1
UMEA UNIVERSITET1
UNIVERSITA DEGLI STUDI DI TORINO1
UNIVERSITA DEGLI STUDI DI VERONA1
UNIVERSITAET BASEL1

Constancy:

Total number of partners: 138
Partner loyalty:
Frequent Partner: (> 2 projects): 23
Rare Partner: 115
Frequent / Rare Partner Ratio: 0.2

Project overview:

Start dateProjectacronymrolefundingpartners
2017-01-01Translational Research Network in Prostate Cancer TransPotparticipant2.629.31618
2015-08-01Investigating eukaryotic replisome dynamics at the single molecule level SMI REPparticipant195.4552
2015-06-01Structural and biochemical characterization of pre-recombination complexes BRCA2Interactcoordinator183.4551
2015-06-01Systematic investigation of the functional coupling between transcriptional and post-transcriptional regulatory interactions underlying tissue-specific 3'UTRs variability. NeuroUTRcoordinator183.4551
2015-05-01Development and immunological control of dendritic cell cancer DC cancercoordinator183.4551
2015-03-01The interplay between innate immunity and RNA interference in mammals RNAi vs IFNparticipant309.2352
2014-09-01Anatomy and dynamics of the human replisome ANDYHREPcoordinator221.6061
2014-06-01Tumour Heterogeneity and Somatic Evolution of Unstable cancer genomes THESEUSparticipant1.999.9412
2014-04-01Structural and biochemical characterization of the BRCA2 breast cancer tumour suppressor BRCA2COMPLEXEScoordinator231.2831
2014-04-01Role of nuclear architecture in cancer development ACTINNUCLSHAPECANCERcoordinator231.2831
2014-01-01Asymmetrical B cell division: origin and functional significance ASYMMETRY IN B CELLScoordinator221.6061
2013-10-01The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy PLOIDYNETparticipant3.017.79011
2013-07-01Design Principles of Microtubule Cytoskeleton Architectures during Cell Division SPINDLEDESIGNparticipant2.497.1151
2013-07-01Single cell level intravital imaging of response, tolerance, and resistance to targeted therapies IMAGEMELTHERAPYLRIcoordinator231.2831
2013-06-01In vitro reconstitution of the replication machinery on a chromatin template DNA REPLICATIONcoordinator221.6061
2013-05-01The dendritic cell receptor DNGR-1: Modulation of endosomal dynamics upon recognition of necrotic cells DNGR-1 IN DCScoordinator221.6061
2013-05-01Targeting RAS oncogene addiction RASTARGETparticipant2.496.2211
2013-05-01Mechanism of Holliday junction dissolution by the Bloom’s Syndrome complex BLMCOMPLEXcoordinator221.6061
2013-04-01Functional analysis of SCOC and FEZ proteins in autophagy using mammalian cell models and zebrafish SCOC AND FEZcoordinator221.6061
2013-04-01Regulation of the Hippo tissue growth pathway by nutrient sensing mechanisms in Drosophila melanogaster HIPPOGAILITEcoordinator221.6061
2012-10-01Generation of a new class of antiretrovirals targeting HIV-cellular cofactors interactions HIVINNOVparticipant6.000.0006
2012-07-31Function of centromeres during meiotic bouquet stage and protein composition of telomeres meiotic centromerescoordinator182.1031
2012-07-01Identification of important regulators of metastasis in pancreatic cancer Cancer metastasiscoordinator200.3721
2012-04-15Gene Discovery in Melanoma Progression and Therapeutic Resistance Melanoma Genesparticipant209.5932
2012-02-01ATMINistrating ATM signalling: exploring the significance of ATM regulation by ATMIN ATMINDDRparticipant1.499.8812
2011-10-01MAL: an actin-regulated SRF transcriptional coactivator ACTINONSRFparticipant1.889.9952
2011-09-01Cross-species characterisation of CD8alpha+ dendritic cells and their role in immune regulation DCSUBSETparticipant2.499.9982
2011-07-01RGS1 in intestinal T cell trafficking and responsiveness RITTARcoordinator209.0931
2011-05-01Imaging influenza nucleic acid recognition by RIG-I in living cells RIG‐I Live Imagingcoordinator200.0501
2011-05-01Transcription and the maintenance of genome integrity TRANSINTEGparticipant1.950.0002
2011-05-01Regulating recombination in mitotic and meiotic cells RECMITMEIparticipant2.379.1042
2011-03-01“The role of ALC1, a novel ATP-dependent chromatin remodelling protein, in transcriptional regulation, tumorigenesis and neurodegeneration” chromALC1hcccoordinator172.7411
2011-02-01Targeting the tumour microenvironment to improve pancreatic cancer prognosis EPC-TM-Netparticipant3.000.00017
2011-02-01The role of Rab7 in axonal retrograde transport and human pathologies retrograde transportcoordinator173.2411
2011-01-01ERA-NET on Translational Cancer Research TRANSCANparticipant1.999.95629
2011-01-01Investigation of a dependency of RAS-driven cancers on matrix metalloproteinase-7 RAS and MMP7coordinator172.7411
2011-01-01Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics PREDICTparticipant5.841.00914
2011-01-01New approaches for the targeted therapy of Non-Small Cell Lung Cancer LUNGTARGETparticipant2.997.33210
2010-10-01Epigenetics towards systems biology EPIGENESYSparticipant11.995.02428
2010-08-01Molecular control of vascular remodelling: A role for Wnt signalling WNT VASCULAR REMODELcoordinator173.2411
2010-07-01Investigating the Functional Implications of MICA Polymorphisms IFIMAPcoordinator172.2411
2010-07-01Breast Cancer Somatic Genetics Study BASISparticipant10.499.99915
2010-07-01The role of hypoxia-inducible factors in human haematopoietic stem cell biology and leukaemogenesis HSCs and HIFcoordinator172.7411
2010-06-01Defects in DNA strand break repair and links to inheritable disease DNArepairparticipant2.449.0912
2010-06-01Telomere function in meiosis Telomeres in meiosisparticipant1.451.9431
2010-05-01The Initiation of Eukaryotic DNA Replication: Mechanism, Regulation and Role in Genome Stability EUKDNAREPparticipant2.449.9992
2010-04-01A molecular view of chromosome condensation ChromoCondparticipant2.076.1261
2010-03-31The role of JNK/c-Jun pathway in axonal damage and neuronal regeneration JNKNeuroregcoordinator171.8681
2010-03-31Functional characterization of indirect dendritic cell activation and its impact on adaptive immunity DC-ACTIVATIONcoordinator181.3511
2010-03-01New imaging methods for detecting treatment response in lymphoma IMAGING LYMPHOMAcoordinator172.7411

overview shows latest 50 from 56 projects (2010-01-01 - 2025-12-31)
A full list of projects can be found here:

Alias institution names:

  • CANCER RESEARCH UK
  • CANCER RESEARCH UK LBG